entertainment -WSS

entertainment

author：fashion 2025-09-02 22:25:53 - browse：7685

Illustration of a person walking across a tightrope, trying to balance. — Adobe

Hospitals are telling government officials it would be illegal to claw back $7.8 billion as part of a remedy that is making hospitals whole over underpaid drug discounts — and they may sue if that plan goes into effect.

The industry is walking a tightrope by trying to maximize the amount of money hospitals can keep. Lobbyists are praising federal officials for agreeing to dole out billions of dollars in future, lump-sum payments, but they are also pressuring Medicare not to offset a penny of those funds.

For several years during the Trump administration, Medicare cut payments for hospitals’ drugs under the federal 340B drug discount program, but the Supreme Court invalidated that policy in 2018. In July, Medicare proposed a solution: Hospitals would get $9 billion to cover what they are owed under the 340B program, but to offset those costs, the government would recoup $7.8 billion.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： Abortion pill case raises question: who can sue the FDA?

explore

WSS

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

Abortion pill case raises question: who can sue the FDA?

CDC's new outbreak response network to include Northeastern

Washington mulls new rules to avert another Change Healthcare

Medical student insurance fails on mental health care coverage

AstraZeneca, Daiichi breast cancer treatment succeeds in trial

hotspot

entertainment

explore

Dobbs anniversary: the lost opportunity of abortion as health care

Readout Newsletter: WuXi and Congress, Boundless Bio, etc.

Walensky prepares to leave CDC — and Congress — behind

Study says nonprofit hospitals fall short in charity care spending

Sports medicine is finally prioritizing gender equality

Experts study whether long Covid risk adds up with each reinfection

Moonlake's readout produced a cash windfall. Risks remain

Microbiome research is starting to find links to chronic diseases

Tori Bowie and the unacceptable rates of Black maternal death

Biotech stock slump in 2023: awaiting the turnaround

hotspot

How Vertex's cystic fibrosis drug is changing patients' lives

Lasker Awards 2023: Winners in biomedical research

Microbiome research is starting to find links to chronic diseases

How Vertex's cystic fibrosis drug is changing patients' lives

Drug for rare kidney disease narrowly misses mark in clinical trial

Hearing on Medicare drug price negotiation gets unusually heated

explore

explore

hotspot

Wikipedia